An artificial "synapse" reads DNA markers like a nerve cell reads signals. In blind trials it caught early prostate cancer with perfect accuracy in 105 patients.
An artificial "synapse" reads DNA markers like a nerve cell reads signals. In blind trials it caught early prostate cancer with perfect accuracy in 105 patients.